INTRODUCTION
============

Plantar fasciitis (PF) is a musculoskeletal system disorder and it is seen on feet most frequently and affects plantar fascia especially ([@b10-jer-14-2-306]; [@b20-jer-14-2-306]). Plantar fascia is the major stabilizer of the longitudinal arch. Therefore, the factors which disrupt the normal biomechanics of feet increase plantar fascia tension. Abnormal tension of plantar fascia that is caused by biomechanical factors does not lead to clinical symptoms at the beginning. However, the stress-causing factors including running, instantly increased activity level, obesity and rapid weight gain, nonorthopedic shoes, long-term standing up or walking and doing activities on a hard surface cause plantar fascia and repetitive microtraumas in other structures and lead to clinical symptoms ([@b28-jer-14-2-306]). In case this situation is not treated, soft tissue calcification starts as a result of microlacerations and thus, calcification and degenerative changes (PF) occur ([@b12-jer-14-2-306]; [@b25-jer-14-2-306]).

The major complaints of patients with PF are stinging and burning pain sensed inside the heel and especially in the heel medial. Pain is excessive at the first steps after getting up in the morning. It alleviates after a few steps however it becomes severe towards the end of the day based on activity. Pain moderates during resting however after the resting it restarts at the first step. Sometimes, slight swelling and erythema occurs. The symptom period may range from several weeks to years ([@b15-jer-14-2-306]).

The treatment-means for PF are divided into surgical and conservative methods. The conservative treatments consist of resting, soft sole supports, heel elevation, night braces keeping the plantar fascia tense at the dorsiflexion, plaster casts, orthosis-type shoe wearing, acupuncture, ultrasound, iontophoresis methods, low density laser application, extracorporeal shockwave therapy, stretching and strengthening exercises, anti-inflammatory (nonsteroid and steroid) medications, cortisone injections and botulinum toxin injection ([@b3-jer-14-2-306]; [@b4-jer-14-2-306]; [@b5-jer-14-2-306]; [@b7-jer-14-2-306]; [@b9-jer-14-2-306]; [@b10-jer-14-2-306]; [@b12-jer-14-2-306]; [@b26-jer-14-2-306]; [@b27-jer-14-2-306]). The conservative therapy is successful 90%--95%. Therefore, the surgical method must be resorted to as an ultimate choice ([@b4-jer-14-2-306]; [@b5-jer-14-2-306]). Studies are conducted comparing various treatment methods in order to find the most effective therapy for PF ([@b9-jer-14-2-306]; [@b11-jer-14-2-306]; [@b12-jer-14-2-306]; [@b16-jer-14-2-306]; [@b19-jer-14-2-306]; [@b27-jer-14-2-306]; [@b30-jer-14-2-306]). It was stated that more detailed studies must be conducted on this subject ([@b9-jer-14-2-306]). Hence, our study was planned to compare the effects of r-ESWT and US therapies and home exercise program for PF treatment.

MATERIALS AND METHODS
=====================

Participants and settings
-------------------------

Eighty-eight female patients were called for the study who applied to our clinic of Physical Medicine and Rehabilitation with heel pain during January 2013 and December 2014 and had heel sensitivity detected by the physical examination with palpation, and had calcaneal spur as seen in feet-lateral grapy and were diagnosed with PF in a single foot. The study was based on volunteerism and the inclusion of the study are; had longer than 3 months of disease duration, were not treated by any physical therapy method previously, received no local steroid injection and did not undergo any surgical procedure, not doing regular exercise and not using any special kind if shoes. The study was started with 78 female patients by leaving 10 patients out of the study due to reflected pain because of their lower extremity pathologies, pregnancy, hemorrhage, neurologic deficit, malignity, using cardiac pacemaker or inflammatory illness story and anticoagulant use. After the first assessment of the patients who complied with the study criteria, the patients were divided randomly into 3 groups namely the r-ESWT+exercise group, the US+exercise group and the exercise group. Randomization was performed by sealed envelope method. As a result of randomization, there were 24 patients in the r-ESWT+exercise group, 26 patients in the US+exercise group and 28 patients in the exercise group. Two patients in the r-ESWT+exercise group left the study because they could not stand pain, two patients were dropped from the study because they did not follow the exercise program and two patients were dropped from the study because they did not continue the treatment. Three patients in the US group left the study because they had the same symptoms starting in their other leg, three patients were dropped from the study because they did not come to the treatment and two patients were dropped from the study because they did not follow the exercise program. Six patients in the exercise group were dropped from the study because they expressed in their follow-up appointment that they did not do their exercises on a regular basis and four patients were dropped from the study because they did not show up for their follow up appointment. Hence, our study was conducted on 54 patients (their average age was 50 and their distribution was 39--59).

In order to conduct the study, the approval and the written, clarified consents of the participants were taken (GO13/218).

The patients were informed about the planned procedure and informed patient consents were received. The study was conducted in accord with Helsinki Declaration. Similar studies were used and an effort analysis was made to designate the patient number prior to the study. The minimum patient number was estimated as 16 for each group with the type I error of α=0.05 and the type II error of β=0.2 and with a 95% confidence interval and ±2 standard deviation (SD).

The patients were informed about the study and informed patient consents were received. At the beginning, the demographic data of all patients, their pain levels in the morning, at night and after the 6-min walking test, their leg fatigue levels after the 6-min walking test and their general fatigue levels were measured by using the visual analogy scale (VAS). Their walking distances were assessed by using the 6-min walking test. Furthermore, the flexor muscle performances of the patients were assessed by using the heel-rise test and their walking speeds were assessed by using the 20-m walking test. These tests were assessed prior to the randomization and at the end of the therapies (4 weeks after the first treatment).

Treatment protocols
-------------------

### r-ESWT therapy

The patients in the first group were treated by Swiss Dolor Clast brand device of the Electro medical Systems SA (EMS) Company (Nyon, Switzerland). The patients were treated as they were lying in prone position. Prior to starting the therapy sessions, the patients' most painful 5 points were uncovered by palpation and marked by a pen. A total of 1,500 pulses of the r-ESWT therapy was applied to each of the five painful points as 0.2 mj/mm^2^, 3.0 Hz of 500 pulses; 0.3 mj/mm^2^, 8 Hz of 300 pulses were applied to the entire heel location and a total of 2,000 pulses of the r-ESWT therapy was applied in each session. Gel was used between the cap and skin during the applications for ensuring conductivity. The therapy was applied in 3 sessions once a week ([@b29-jer-14-2-306]).

### US therapy

It was applied to the patients in the second group by using Gymna Pulson 200 device. The therapy was applied as the patients were lying in prone position and by longitudinal movements along the entire plantar fascia. The US therapy was applied at 3.0-MHz frequency and as 20% intermittently with 1 W/cm^2^ of power for 8 min. Gel was used between the US cap and skin during the applications for ensuring conductivity ([@b17-jer-14-2-306]). The patients were treated in a total 7 sessions 2 days a week (to equate treatment time with r-ESWT therapy).

### The exercise program

Home exercise programs were applied in all three groups of patients. The patients were trained on the exercise program and subsequently provided with an exercise form for marking the exercise dates and sessions. The patients were asked to do these exercises 10 times by counting up to 30 for a total of 4 weeks in the mornings and at nights starting from the first assessment until the second assessment. The home exercise program consisted of Achilles tendon stretching by sitting, gastrocnemius and gastrosoleus muscles stretching as standing up and plantar fascia stretching on steps ([@b8-jer-14-2-306]).

Statistical analysis
--------------------

The data were analyzed by SPSS ver. 15.0 (SPSS Inc., Chicago, IL, USA) and via descriptive statistics analysis (frequency, mean, minimum and maximum, and SD). Before starting the study, a power analysis was performed to determine the number of patients required. The Kolmogorov--Smirnov test was used to determine whether data distribution was normal, and it was determined that the data did not have a normal distribution. We therefore used the Wilcoxon signed rank test to compare the treatment groups' data before and after the treatment. The Kruskal--Wallis test was used to determine the group causing the differences between the three groups. The Mann--Whitney *U*-test was used to make comparisons between the two groups. The statistical significance level was a *P*-value of less than 0.05, and we used 95% confidence intervals.

RESULTS
=======

There were no differences found between the demographic features of the groups including their educational status and body mass indexes (BMIs) (*P*\>0.05) ([Table 1](#t1-jer-14-2-306){ref-type="table"}).

The values of the participants prior to the therapies are shown in [Table 1](#t1-jer-14-2-306){ref-type="table"}. The values of pain before the therapies, fatigue after a 6-min walk, 6-min walking distance, heel-rise test scores and 20-m walking speed were found similar in the three groups (*P*\>0.05) ([Table 2](#t2-jer-14-2-306){ref-type="table"}).

The pain and fatigue levels decreased following the therapies in the three groups and their 6-min walking distances and heel rise test scores increased (*P*\<0.05). The 20-m walking speed increased in the US and r-ESWT groups (*P*\<0.05) following the therapies and there was no different found in the Ex group (*P*\>0.05) ([Table 3](#t3-jer-14-2-306){ref-type="table"}).

By comparing the groups with each other following the therapies, pain before bedtime at nights and leg fatigue after a 6-min walk decreased more in the US group (*P*\<0.05). The groups were similar in terms of morning pain, pain after a 6-min walk, fatigue after a 6-min walk (*P*\>0.05). Also 6-min walking distance, heel rise test scores and 20-min walking speed were similar in three groups (*P*\>0.05) ([Table 4](#t4-jer-14-2-306){ref-type="table"}).

DISCUSSION
==========

In our study, we aimed to assess the acute effects of the r-ESWT, US, and exercise therapies for PF immediately after the therapies and we formed three groups namely the r-ESWT and exercise groups, the US and exercise groups and only the exercise group. At the end of the study, it was designated that the patients in all three groups got better after the therapies primarily the patients in the US group. In this group, pain before bedtime at nights and leg fatigue after a 6-min walk diminished more in comparison to the other groups.

PF is the most frequent cause of heel pain. Despite the conservative methods are used during therapies including steroid injection, nonsteroid anti-inflammatory medication, iontophoresis, laser, ultrasound, ESWT, orthotic support therapy and exercise therapies ([@b9-jer-14-2-306]; [@b14-jer-14-2-306]; [@b26-jer-14-2-306]; [@b30-jer-14-2-306]), there is no consensus about the most successful treatment method ([@b18-jer-14-2-306]; [@b25-jer-14-2-306]). Therefore, our study is unique since we organized it to compare the effects of r-ESWT and US therapies applied in combination with the exercise therapy for PF treatment and included a group doing only home exercises.

The descriptive features of our cases including age, BMI, education and occupation status, and dominant leg activations were similar in the three groups and we think that they may affect our assessments in our study, exercise program implementation and the therapy success. This showed us that we conducted our study on homogenous groups.

Another result of our study indicating to the homogeneity of the groups was that pain before the therapies, heel rise test scores, 6-min walking distance, leg fatigue level after a 6-min walk and general fatigue level and 20-m walking speed results were similar in the three groups.

Pain is the major complaint of patients with PF. Pain on medial calcaneal tubercle is generally unbearable in the first step taken in the morning and this pain moderates somewhat after a few steps and increase again after long-term activity and before bedtime at nights ([@b12-jer-14-2-306]). As a result of our study, morning pain, pain before bedtime at nights and pain after the 6-min walking test decreased in the three groups after the therapies. Pain before bedtime at nights moderated more in the US group. This showed us that all three therapy methods were effective to decrease pain however the ultrasound therapy was even more influential for moderating pain that increase with activity. Upon the literature search, there were no studies found comparing the effects of r-ESWT and US therapies on pain however in the literature, the studies conducted on the effects of the ESWT, US, and exercise applications on pain reported that these practices were effective on pain moderation ([@b2-jer-14-2-306]; [@b19-jer-14-2-306]; [@b24-jer-14-2-306]; [@b25-jer-14-2-306]; [@b27-jer-14-2-306]; [@b30-jer-14-2-306]) and these results were parallel to our study.

Another parameter assessed in our study was fatigue. The general fatigue levels of the patients and their leg fatigue after the 6-min walking test were assessed by using the VAS and it was uncovered that the fatigue levels of the three groups went down after the therapies. However, it was exhibited that their leg fatigues after the 6-min walking test alleviated even more in the US group in comparison to the other groups. This made us think that this situation occurred because the pain that escalated with activity was more moderate in the US group in comparison to the other two groups.

Walking is one of the activities affected in PF. In our study, the 6-min walking test distances were assessed and found that this distance increased in all of the three groups after the therapies and there were no difference between the groups. [@b6-jer-14-2-306] studied the effects of the ESWT therapy in patients with PF and found that the patients' painless walking distances increased in parallel to our results.

Heel rising is a frequently used activity in daily life and at the same time it is a phase of walking and patients with PF have difficulty doing it since plantar fascia stretches during this activity. Individuals may face difficulty during heel lifting and due to pain inflicted during walking and their walking speed also may slow down. We assessed the heel-rise test scores because of these reasons and despite the patients' heel-rise test scores and 20-m walking speeds were similar prior to the therapies, they increased in all of the three groups after the therapies and there were no differences found between the groups. In the literature, there were no studies found conducted on walking speeds of patients with PF. Furthermore, there were no studies found investigating the effects of the applied therapies on heel rise and walking speed either. However, there are studies investigating the effects of pain on walking distance and functionality in various patient groups and reporting that as the pain severity increased, the individuals' walking speeds and functionality levels dropped ([@b1-jer-14-2-306]; [@b13-jer-14-2-306]). As a result of our study, in parallel to this information, we think that the increased heel-rise test scores and walking speeds of the patients stem from their moderated pain.

Considering our literature search about the parameters that we applied generally, despite there are many studies on ESWT and r-ESWT in PF, there is no consensus reached about the therapy protocol as far as the pulse number, pressure and application frequency are concerned. It is difficult to make a comparison between the studies since various tools were used and different protocols were applied in the studies ([@b21-jer-14-2-306]). [@b22-jer-14-2-306] reported as a result of their study that the effects of shockwaves emerged based on dosage and an appropriate dose was not designated yet. It was thought that the diversity of patient population and the variation of applied dosages influenced the evidence level in the US therapy just like in the ESWT and therefore the most appropriate dose was not able to be designated ([@b17-jer-14-2-306]). Moreover, the superiority of stretching exercises to one another was researched and considering their short-term results, plantar fascia stretching exercises were reported to be more effective in comparison to the Achilles tendon stretching exercises however it was pointed out that the stretching exercises must be combined ([@b11-jer-14-2-306]; [@b23-jer-14-2-306]). The review studies conducted on patients with PF showed that a single therapy modality for PF treatment was generally inadequate and more than one therapy modality must be used in combination. In our study, we concluded that the US therapy combined with exercises and the r-ESWT therapy combined with exercises were more successful on some parameters such as walking speed in comparison to the exercise therapy alone. However, we recommend that home exercise programs must be applied for patients with PF, whose treatment is not possible in a clinic environment since it would moderate patients' pain and improve their functionality, walking speed and walking distance.

This study had some limitations. Our limitations were using of subjective measures and not having control group without doing home exercise and the lack of therapy groups for whom no home exercise program was applied.

In conclusion, as a result of our study it was seen that the exercise therapy, and the US therapy and the r-ESWT therapy applied in combination with the exercise therapy were effective methods for moderating pain and improving walking distance, walking speed and functionality. It was seen that the US+exercise therapy for patients with PF was more superior than the exercise therapy, and the r-ESWT therapy combined with the exercise therapy for moderating pain before bedtime at nights. Nevertheless, it was concluded that further studies needed to be conducted for comparing the applications of the r-ESWT and US therapies performed with various dosages, diagnoses, and consisting of a combination of more different therapy modalities and using wider samplings.
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###### 

Patient demographics

  Variable                    r-ESWT group (n=18)         US group (n=18)             Ex group (n=18)             Chi-squre[a)](#tfn3-jer-14-2-306){ref-type="table-fn"}   *P*-value
  --------------------------- --------------------------- --------------------------- --------------------------- -------------------------------------------------------- -----------
  Age (yr)                    50.00±6.54 (39--59)         50.11±9.29 (32--65)         45.22±7.64 (32--62)         4.596                                                    0.100
  Education level (yr)        3.94±3.75 (1--11)           3.22±4.04 (0--11)           3.78±4.02 (0--11)           3.281                                                    0.703
  Body mass ındex (kg/m^2^)   28.58±1.67 (23.51--29.94)   28.48±2.15 (21.97--29.94)   28.03±2.04 (22.95--29.97)   1.299                                                    0.522

Values are presented as mean±standard deviation (range).

r-ESWT, radial extracorporeal shock wave therapy; US, ultrasound therapy; Ex, exercise therapy.

Kruskal--Wallis test.

###### 

Patients' pretreatment evaluation results

  Before treatment                     r-ESWT group   US group     Ex group     Chi-squre[a)](#tfn6-jer-14-2-306){ref-type="table-fn"}   *P*-value
  ------------------------------------ -------------- ------------ ------------ -------------------------------------------------------- -----------
  Pain (cm)                                                                                                                              
   Morning pain                        9.33±1.41      9.50±1.29    8.50±2.55    1.182                                                    0.554
   Pain before bedtime                 9.00±1.75      8.83±1.86    9.06±1.80    0.147                                                    0.929
   Pain after 6-min walk test          3.78±3.44      8.17±2.18    7.39±1.97    4.704                                                    0.095
                                                                                                                                         
  Fatique after 6-min walk test (cm)                                                                                                     
   General fatique                     6.94±2.53      5.22±3.42    4.83±3.03    5.670                                                    0.059
   Leg fatique                         6.72±2.35      4.11±3.80    4.28±3.82    5.079                                                    0.079
   Distance of 6-min walk test (m)     366±94         359±88       400±58.21    3.273                                                    0.195
   Heel rise test score (pcs/min)      9.00±6.53      10.89±5.79   10.00±6.36   1.041                                                    0.594
   20-m walk speed (sn)                10.72±3.06     11.28±3.29   9.78±2.07    2.156                                                    0.340

Values are presented as mean±standard deviation.

r-ESWT, radial extracorporeal shock wave therapy; US, ultrasound therapy; Ex, exercise therapy.

Kruskal--Wallis test.

###### 

Comparision of the groups' results before and after treatment

  Variable                              r-ESWT group   US group     Ex group                                                                                         
  ------------------------------------- -------------- ------------ ---------- ------- ------------ ------------ -------- ------- ------------ ------------ -------- -------
  Pain (cm)                                                                                                                                                          
   Morning                              9.33±1.41      4.94±4.12    −3.304     0.001   9.50±1.29    3.72±2.47    −3.754   0.001   8.50±2.55    5.61±3.58    −2.871   0.004
   Before bedtime                       9.00±1.75      5.94±3.64    −2.809     0.005   8.83±1.86    3.89±2.35    −3.530   0.001   9.06±1.80    6.39±2.75    −2.821   0.005
   After 6-min walk test                3.78±3.44      3.78±3.44    −3.366     0.001   8.17±2.18    3.17±3.37    −3.303   0.001   7.39±1.97    4.83±2.62    −3.079   0.002
   Fatique after 6-min walk test (cm)                                                                                                                                
                                                                                                                                                                     
  General fatique                       6.94±2.53      3.72±3.18    −3.195     0.001   5.22±3.42    1.94±2.36    −2.941   0.003   4.83±3.03    2.89±2.97    −1.799   0.072
   Leg fatique                          6.72±2.35      3.72±2.85    −3.045     0.002   4.11±3.80    1.28±1.81    −2.558   0.011   4.28±3.82    2.72±3.56    −1.476   0.140
   Distance of 6-min walk test (m)      366±94         486±112      −3.413     0.001   359±88       473±144      −3.420   0.001   400±58.21    455±92       −2.352   0.019
   Heel rise test score (pcs/min)       9.00±6.53      15.83±5.25   −3.520     0.001   10.89±5.79   18.72±8.93   −2.899   0.004   10.00±6.36   18.11±7.37   −3.466   0.001
   20-m walk speed (sn)                 10.72±3.06     8.33±1.72    −3.457     0.001   11.28±3.29   8.72±2.72    −3.421   0.001   9.78±2.07    8.67±1.94    −1.862   0.063

Values are presented as mean±standard deviation. Wilcoxon signed ranks test.

r-ESWT, radial extracorporeal shock wave therapy; US, ultrasound therapy; Ex, exercise therapy; BT, before treatment; AT, after treatment.

###### 

Patients' posttreatment evaluation results

  After treatment                      r-ESWT group                                              US group                                                                                                Ex group                                                  Chi-squre[c)](#tfn13-jer-14-2-306){ref-type="table-fn"}   *P*-value
  ------------------------------------ --------------------------------------------------------- ------------------------------------------------------------------------------------------------------- --------------------------------------------------------- --------------------------------------------------------- -----------
  Pain (cm)                                                                                                                                                                                                                                                                                                                  
   Morning pain                        4.94±4.12                                                 3.72±2.47                                                                                               5.61±3.58                                                 2.566                                                     0.277
   Pain before bedtime                 5.94±3.64                                                 3.89±2.35[a](#tfn11-jer-14-2-306){ref-type="table-fn"},[b)](#tfn12-jer-14-2-306){ref-type="table-fn"}   6.39±2.75[b)](#tfn12-jer-14-2-306){ref-type="table-fn"}   6.922                                                     0.031
   Pain after 6-min walk test          3.78±3.44                                                 3.17±3.37                                                                                               4.83±2.62                                                 2.677                                                     0.262
                                                                                                                                                                                                                                                                                                                             
  Fatique after 6-min walk test (cm)                                                                                                                                                                                                                                                                                         
   General fatique                     3.72±3.18                                                 1.94±2.36                                                                                               2.89±2.97                                                 3.214                                                     0.200
   Leg fatique                         3.72±2.85[a)](#tfn11-jer-14-2-306){ref-type="table-fn"}   1.28±1.81[a](#tfn11-jer-14-2-306){ref-type="table-fn"},[b)](#tfn12-jer-14-2-306){ref-type="table-fn"}   2.72±3.56                                                 6.289                                                     0.043
   Distance of 6-min walk test (m)     486±112                                                   473±144                                                                                                 455±92                                                    0.352                                                     0.839
   Heel rise test score (pcs/min)      15.83±5.25                                                18.72±8.93                                                                                              18.11±7.37                                                1.254                                                     0.534
   20-m walk speed (sn)                8.33±1.72                                                 8.72±2.72                                                                                               8.67±1.94                                                 0.161                                                     0.923

Values are presented as mean±standard deviation.

r-ESWT, radial extracorporeal shock wave therapy; US, ultrasound therapy; Ex, exercise therapy.

According to Mann Whitney *U*-test, there is difference between the r-ESWT vs. US groups.

According to Mann Whitney *U*-test, there is difference between the US and Control groups.

Kruskal--Wallis test.
